Back to Top
Test Kits
LumiraDx™ SARS-CoV-2 Ag Antigen Detection Respiratory Test Kit
- Results in 12 minutes
- Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen; antigen is generally detectable in nasal swab specimens during the acute phase of infection.
- The LumiraDx SARS-CoV-2 Ag test does not differentiate between SARS-CoV and SARS-CoV-2.
- Rapid microfluidic immunofluorescence assay test method
- LumiraDx SARS-CoV-2 Ag Test is for use under an Emergency Use Authorization only.
- Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C 263a, that meet the requirements to perform moderate, high or waived complexity tests.
- Test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
- LumiraDx SARS-CoV-2 Ag Test is intended for use by trained clinical laboratory personnel and individuals trained in point of care settings, and proficient in performing tests using the LumiraDx Instrument.
- 48 tests
In stock
SKU
1197690_EA
$50.00
Respiratory Test Kit LumiraDx™ SARS-CoV-2 Ag 48 Tests CLIA Waived
Write Your Own Review
Write your content here...
